XML 26 R12.htm IDEA: XBRL DOCUMENT v3.24.0.1
Note 3 - Cash, Cash Equivalents, Investments and Restricted Cash
12 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Financial Instruments Disclosure [Text Block]

3.  CASH, CASH EQUIVALENTS, INVESTMENTS AND RESTRICTED CASH

 

The following is a summary of the Company’s cash, cash equivalents and debt investments (in thousands): 

 

  

December 31,

 
  

2023

  

2022

 

Cash

 $392,329  $273,145 

Money market funds

  135,514   15,462 

Certificates of deposit

  127,123   130,467 

Corporate debt securities

  95,101   292,586 

Commercial paper

  -   17,928 

U.S. treasuries and government agency bonds

  358,409   8,285 

Auction-rate securities backed by student-loan notes

  567   1,711 

Total

 $1,109,043  $739,584 

 

 

  

December 31,

 
  

2023

  

2022

 

Reported as:

        

Cash and cash equivalents

 $527,843  $288,607 

Short-term investments

  580,633   449,266 

Investment within other long-term assets

  567   1,711 

Total

 $1,109,043  $739,584 

 

 

The following table summarizes the contractual maturities of the short-term and long-term available-for-sale investments as of December 31, 2023 (in thousands): 

 

  

Amortized Cost

  

Fair Value

 

Due in less than 1 year

 $398,670  $397,884 

Due in 1 - 5 years

  183,266   182,749 

Due in greater than 5 years

  574   567 

Total

 $582,510  $581,200 

 

 

Gross realized gains and losses were not material for the periods presented.

 

The following tables summarize the unrealized gain and loss positions related to the available-for sale investments (in thousands): 

 

  

December 31, 2023

 
  

Amortized Cost

  

Unrealized Gains

  

Unrealized Losses

  

Fair Value

 

Money market funds

 $135,514  $-  $-  $135,514 

Certificates of deposit

  127,123   -   -   127,123 

Corporate debt securities

  96,636   4   (1,539)  95,101 

U.S. treasuries and government agency bonds

  358,177   327   (95)  358,409 

Auction-rate securities backed by student-loan notes

  574   -   (7)  567 

Total

 $718,024  $331  $(1,641) $716,714 

 

  

December 31, 2022

 
  

Amortized Cost

  

Unrealized Gains

  

Unrealized Losses

  

Fair Value

 

Money market funds

 $15,462  $-  $-  $15,462 

Certificates of deposit

  130,467   -   -   130,467 

Corporate debt securities

  300,529   18   (7,961)  292,586 

Commercial paper

  17,928   -   -   17,928 

U.S. treasuries and government agency bonds

  8,487   -   (202)  8,285 

Auction-rate securities backed by student-loan notes

  1,770   -   (59)  1,711 

Total

 $474,643  $18  $(8,222) $466,439 

 

The following tables present information about the available-for-sale investments that had been in a continuous unrealized loss position for less than 12 months and for greater than 12 months (in thousands):

 

  

December 31, 2023

 
  

Less than 12 Months

  

Greater than 12 Months

  

Total

 
  

Fair Value

  

Unrealized Losses

  

Fair Value

  

Unrealized Losses

  

Fair Value

  

Unrealized Losses

 

Corporate debt securities

 $20,792  $(19) $70,806  $(1,520) $91,598  $(1,539)

U.S. treasuries and government agency bonds

  97,599   (95)  -   -   97,599   (95)

Auction-rate securities backed by student-loan notes

  -   -   567   (7)  567   (7)

Total

 $118,391  $(114) $71,373  $(1,527) $189,764  $(1,641)

 

  

December 31, 2022

 
  

Less than 12 Months

  

Greater than 12 Months

  

Total

 
  

Fair Value

  

Unrealized Losses

  

Fair Value

  

Unrealized Losses

  

Fair Value

  

Unrealized Losses

 

Corporate debt securities

 $72,943  $(973) $202,074  $(6,988) $275,017  $(7,961)

U.S. treasuries and government agency bonds

  987   (2)  7,298   (200)  8,285   (202)

Auction-rate securities backed by student-loan notes

  -   -   1,711   (59)  1,711   (59)

Total

 $73,930  $(975) $211,083  $(7,247) $285,013  $(8,222)

 

 

An impairment exists when the fair value of an investment is less than its amortized cost basis. As of December 31, 2023 and 2022, the Company did not consider the impairment of its investments to be a result of credit losses. The Company typically invests in highly rated securities, with the primary objective of minimizing the potential risk of principal loss. The Company’s investment policy generally requires securities to be investment grade and limits the amount of credit exposure to any one issuer. When evaluating a debt security for impairment, management reviews factors such as the Company’s intent to sell, or whether it will more likely than not be required to sell, the security before recovery of its amortized cost basis, the extent to which the fair value of the security is less than its cost, the financial condition of the issuer and the credit quality of the investment.

 

Non-Marketable Equity Investment

 

In November 2020, the Company made an equity investment in a privately held Swiss company (the “Investee”) that is accounted for under the measurement alternative. In April 2022, the Company made an additional investment in the form of a convertible loan. One member of the Board of Directors was an executive officer of a company that has a commercial relationship with the Investee. In addition, the Company’s Chief Executive Officer had a personal investment in the Investee and was on the Investee’s Board of Directors. As of December 31, 2022, the Company’s investment in the Investee, which is denominated in Swiss Franc, had a carrying value of $5.4 million.

 

In May 2023, the Company sold all its investments in the Investee for $7.4 million and recorded a gain of $1.4 million, which was included as a component of other income (expense), net, in the Consolidated Statements of Operations for the year ended December 31, 2023.

 

Restricted Cash

 

The following table provides a reconciliation of cash, cash equivalents and restricted cash reported on the Consolidated Balance Sheets to the amounts reported on the Consolidated Statements of Cash Flows (in thousands):   

 

  

December 31,

 
  

2023

  

2022

 

Cash and cash equivalents

 $527,843  $288,607 

Restricted cash included in other current assets

  33,204   - 

Restricted cash included in other long-term assets

  134   122 

Total cash, cash equivalents and restricted cash reported on the Consolidated Statements of Cash Flows

 $561,181  $288,729 

 

As of December 31, 2023, restricted cash included in other current assets was related to preliminary purchase consideration held in a trust account in connection with the Company’s recent acquisition. See Note 17 for additional information. As of December 31, 2023 and 2022, restricted cash included in other long-term assets was related to a security deposit that is set aside in a bank account and cannot be withdrawn by the Company under the terms of a lease agreement. The restriction will end upon the expiration of the lease.